MedTrace Logo

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

NCT00242944 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 307

Last updated 2023-10-04

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of pitavastatin and atorvastatin on coronary plaque volume in patients with acute coronary syndrome and to clarify the relationship between coronary plaque volume, serum lipids, and inflammation markers in order to determine the significance of intensive lipid lowering therapy in patients with acute coronary syndrome in Japan.

Conditions

Interventions

DRUG

Pitavastatin

Pitavastatin 4mg per day

DRUG

Atorvastatin

Atorvastatin 20mg per day

Sponsors & Collaborators

  • Yamaguchi University Hospital

    collaborator OTHER

  • Juntendo University

    collaborator OTHER

  • Kyoto University

    lead OTHER

Principal Investigators

  • Masunori Matsuzaki, MD, PhD · Professor of Medicine, Department of Cardiovascular Medicine, Yamaguchi University Graduate School of Medicine

  • Hiroyuki Daida, MD · Professor of Medicine, Department of Cardiovascular Medicine, Juntendo University School of Medicine

  • Takeshi Kimura, MD · Associate Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-10-31
Completion
2008-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00242944 on ClinicalTrials.gov